tiprankstipranks
Trending News
More News >
Viking Therapeutics (VKTX)
NASDAQ:VKTX
US Market

Viking Therapeutics (VKTX) Income Statement

Compare
7,171 Followers

Viking Therapeutics Income Statement

Last quarter (Q3 2025), Viking Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Viking Therapeutics's net income was $-90.79M. See Viking Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -292.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 150.92M$ 100.83M$ 70.36M$ 55.68M$ 42.66M
Depreciation and Amortization
$ 346.00K$ 292.00K$ 291.00K$ 296.00K$ 277.00K
EBITDA
$ -150.57M$ -100.53M$ -70.06M$ -55.39M$ -39.11M
Operating Income
$ -150.92M$ -100.83M$ -70.36M$ -55.68M$ -42.66M
Other Income/Expenses
$ 40.96M$ 14.93M$ 1.49M$ 692.00K$ 3.17M
Pretax Income
$ -109.96M$ -85.89M$ -68.87M$ -54.99M$ -39.49M
Net Income
$ -109.96M$ -85.89M$ -68.87M$ -54.99M$ -39.49M
Per Share Metrics
Basic EPS
$ -1.01$ -0.91$ -0.88$ -0.70$ -0.50
Diluted EPS
$ -1.01$ -0.91$ -0.88$ -0.70$ -0.50
Weighted Average Shares Outstanding
109.04M 94.35M 76.83M 77.20M 72.60M
Weighted Average Shares Outstanding (Diluted)
109.04M 94.35M 76.83M 77.20M 72.60M
Currency in USD

Viking Therapeutics Earnings and Revenue History